Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P Tew

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumorsA Craig Lockhart, Mace L Rothenberg, Jakob Dupont, et al.
Annals of Surgical Oncology|October 30, 2015
Is It Time to Centralize Ovarian Cancer Care in the United States?Renee A Cowan, Roisin E O'Cearbhaill, Ginger J Gardner, et al.
Gynecologic Oncology|November 20, 2020
Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary studyThomas Boerner, Edward Tanner, Olga Filippova, et al.
Cancers|March 11, 2023
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third RemissionBeryl L Manning-Geist, Sacha Gnjatic, Carol Aghajanian, et al.
Gynecologic Oncology|March 23, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugatePaul Johannet, Matthew Flint, M Herman Chui, et al.
Gynecologic Oncology|January 2, 2021
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary StudyThomas Boerner, Henry S Walch, Bastien Nguyen, et al.
Gynecologic Oncology|November 3, 2020
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancersMaria M Rubinstein, Rachel N Grisham, Karen Cadoo, et al.
Cancer|May 26, 2018
Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancerEnrique Soto-Perez-de-Celis, Can-Lan Sun, William P Tew, et al.
Cancer|December 28, 2019
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathwayMaria M Rubinstein, David M Hyman, Imogen Caird, et al.
Gynecologic Oncology|November 12, 2021
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancerBeryl L Manning-Geist, Sushmita B Gordhandas, Dilip D Giri, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumorsA Craig Lockhart, Mace L Rothenberg, Jakob Dupont, et al.
Annals of Surgical Oncology|October 30, 2015
Is It Time to Centralize Ovarian Cancer Care in the United States?Renee A Cowan, Roisin E O'Cearbhaill, Ginger J Gardner, et al.
Gynecologic Oncology|November 20, 2020
Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary studyThomas Boerner, Edward Tanner, Olga Filippova, et al.
Cancers|March 11, 2023
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third RemissionBeryl L Manning-Geist, Sacha Gnjatic, Carol Aghajanian, et al.
Gynecologic Oncology|March 23, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugatePaul Johannet, Matthew Flint, M Herman Chui, et al.
Gynecologic Oncology|January 2, 2021
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary StudyThomas Boerner, Henry S Walch, Bastien Nguyen, et al.
Gynecologic Oncology|November 3, 2020
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancersMaria M Rubinstein, Rachel N Grisham, Karen Cadoo, et al.
Cancer|May 26, 2018
Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancerEnrique Soto-Perez-de-Celis, Can-Lan Sun, William P Tew, et al.
Cancer|December 28, 2019
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathwayMaria M Rubinstein, David M Hyman, Imogen Caird, et al.
Gynecologic Oncology|November 12, 2021
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancerBeryl L Manning-Geist, Sushmita B Gordhandas, Dilip D Giri, et al.
Pageof 12